Moreover, mutations in the PIK3 catalytic subunit alpha (PIK3CA) gene, which occur in approximately 40% of patients with HR-positive, HER2-negative breast cancer, predict worse survival outcomes. The gene discussed is PIK3CA; the disease is breast cancer.